Dual‐ Sabatier Optima: How Reaction Mechanism Determines Activity Volcano Map of Dual‐Atom Catalysts for Oxygen Reduction Reaction
Angewandte Chemie International Edition · 08.06.2026 · 65 (24)
DOI: 10.1002/anie.8386838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 27.04.2026. Verfasst von Jin Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Dual‐atom catalysts (DACs) have demonstrated superior potential in the oxygen reduction reaction (ORR). However, the single‐peak activity volcano derived from classical associative mechanism is contrast to the large‐scale experimental data from the Digital Catalysis Platform ( DigCat ). Herein, we studied ORR over 200 DACs from thermodynamic and kinetic perspectives, and found that the dissociative mechanism is generally dominant for DACs. By integrating potential‐related microkinetic modeling and machine learning (ML)‐derived interpretable structural descriptors, we discovered a dual‐ Sabatier optima volcano map against Δ G (OH*) (or structural descriptors), which was rigorously validated against available experimental data. Dual‐ Sabatier optima stem from the rate‐determining step of dissociative mechanism switching among three elementary reactions (O 2 dissociation → 2OH protonation → OH protonation), which can be extended across DACs containing transition metal, metal‐like, and non‐metal elements as center atoms. It opens a brand‐new perspective for rational design of DACs and atomically dispersed catalysts for other reactions beyond ORR, of which the dominant reaction mechanism may be different from single‐atom catalysts (SACs) and lead to diverse activity volcano maps. Most importantly, this work illustrates that new phenomenon can be identified from “old experimental data” under a large data scale, with the help of theoretical simulations integrated with interpretable ML .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China.
- Beijing Key Laboratory of Intelligent Design and Manufacturing for Hydrogen Energy Materials, Beijing University of Chemical Technology, Beijing, China.
- Advanced Institute for Materials Research (WPI-AIMR), Tohoku University, Sendai, Japan.
- Deep Intelligence Experiment Technology (Beijing) Co., Ltd, Beijing, China.
ORCID-Profile: Hao Li, Haoxiang Xu, Daojian Cheng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- JSPS
- State Key Laboratory of Organic-Inorganic Composites
- Japan Society for the Promotion of Science
Zitieren
APA
Liu, J., Li, H., Xu, H., & Cheng, D. (2026). Dual‐ Sabatier Optima: How Reaction Mechanism Determines Activity Volcano Map of Dual‐Atom Catalysts for Oxygen Reduction Reaction. Angewandte Chemie International Edition, 65(24). https://doi.org/10.1002/anie.8386838
Vancouver
Liu J, Li H, Xu H, Cheng D. Dual‐ Sabatier Optima: How Reaction Mechanism Determines Activity Volcano Map of Dual‐Atom Catalysts for Oxygen Reduction Reaction. Angewandte Chemie International Edition. 2026;65(24). doi:10.1002/anie.8386838
BibTeX
@article{Liu2026,
author = {Liu, Jin and Li, Hao and Xu, Haoxiang and Cheng, Daojian},
title = {Dual‐ Sabatier Optima: How Reaction Mechanism Determines Activity Volcano Map of Dual‐Atom Catalysts for Oxygen Reduction Reaction},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {24},
doi = {10.1002/anie.8386838}
}
EUVIMED